⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Alkermes plc and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Alkermes plc
↗Dublin, Ireland
Alkermes plc is a global biopharmaceutical company headquartered in Dublin, Ireland, with significant R&D and manufacturing operations in the United States and Ireland. The company specializes in the research, development, and commercialization of innovative medicines, primarily focusing on neuroscience, including treatments for central nervous system (CNS) disorders such as schizophrenia, bipolar I disorder, addiction, and sleep disorders.
Following its acquisition of Avadel Pharmaceuticals in early 2026, Alkermes has significantly expanded its sleep medicine portfolio, notably adding LUMRYZ (sodium oxybate) to its commercial offerings. The company is currently advancing a pipeline centered on orexin 2 receptor agonism for various neurological conditions, including narcolepsy, idiopathic hypersomnia, ADHD, and fatigue associated with multiple sclerosis and Parkinson's disease.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Neuroscience/CNS therapeutics
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$1B-$2B
Founded:1987
Ownership:public
Status:operating
STOCK
Exchange:NASDAQ
Ticker:ALKS
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial / Phase 3
Modalities:Small molecule
Trial Phases:-
CORPORATE STRUCTURE
Subsidiaries:Alkermes, Inc., Alkermes Science Five Limited, Alkermes Controlled Therapeutic, Daravuta Pharma Ireland Limited
Key Partnerships:Biogen, AstraZeneca, Johnson & Johnson, Acorda Therapeutics
COMPETITION
Position:Leader
Competitors:Lundbeck, Jazz Pharmaceuticals, Neurocrine Biosciences
LEADERSHIP
Key Executives:
Richard Pops - CEO (Retiring July 31, 2026)
Blair Jackson - Incoming CEO (Effective Aug 1, 2026)
Craig Hopkinson - Chief Medical Officer and EVP, R&D
LINKS
Website:alkermes.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Alkermes plc. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.